Home  |  Contact

Cellosaurus SH-SY5Y-TrkB, clone BR6 (CVCL_UJ95)

[Text version]

Cell line name SH-SY5Y-TrkB, clone BR6
Synonyms SY5Y-TrkB, clone BR6; SH-SY5Y-TrkB, BR6
Accession CVCL_UJ95
Resource Identification Initiative To cite this cell line use: SH-SY5Y-TrkB, clone BR6 (RRID:CVCL_UJ95)
Comments Doubling time: 18-24 hours (Kerafast).
Transfected with: HGNC; 8032; NTRK2.
Sequence variations ALK p.Phe1174Leu (c.3522C>A) (from parent cell line).
Disease Neuroblastoma (NCIt: C3270)
Neuroblastoma (ORDO: Orphanet_635)
Derived from metastatic site: Bone marrow.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0019 (SH-SY5Y)
Sex of cell Female
Age at sampling 4Y
Category Cancer cell line
Web pages https://www.kerafast.com/product/3180/trk-sh-sy5y-neuroblastoma-cell-lines
Publications

PubMed=25684664; DOI=10.1016/j.canlet.2015.02.011
Iyer R., Croucher J.L., Chorny M., Mangino J.L., Alferiev I.S., Levy R.J., Kolla V., Brodeur G.M.
Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma.
Cancer Lett. 360:205-212(2015)

PubMed=26797418; DOI=10.1016/j.canlet.2016.01.018
Iyer R., Wehrmann L., Golden R.L., Naraparaju K., Croucher J.L., MacFarland S.P., Guan P., Kolla V., Wei G., Cam N., Li G., Hornby Z., Brodeur G.M.
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.
Cancer Lett. 372:179-186(2016)

Entry history
Entry creation25-Feb-2019
Last entry updated12-Mar-20
Version number2